• 1. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 2. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 3. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 4. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Triterpene saponins

Aesculioside C: A Comprehensive Overview

Aesculioside C, also known by its CAS number 254896-65-6, is a bioactive compound that has garnered significant attention in the fields of pharmacology and natural product research. This compound is a member of the saponin class, which are glycosides with triterpenoid or steroid aglycones. Aesculioside C has been isolated from various plant sources, particularly species belonging to the genus Aesculus, commonly known as horse chestnut trees. Its unique chemical structure and diverse biological activities make it a promising candidate for drug development and nutraceutical applications.

The structural elucidation of Aesculioside C has been a focal point of recent studies. Using advanced analytical techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry, researchers have identified its complex glycosidic bonds and triterpene backbone. The molecule consists of a triterpenoid aglycone linked to multiple sugar units, which contribute to its hydrophilic properties and bioavailability. These structural features are crucial for understanding its pharmacokinetics and interactions with cellular targets.

One of the most compelling aspects of Aesculioside C is its diverse range of biological activities. Recent studies have demonstrated its potent anti-inflammatory properties, making it a potential candidate for treating inflammatory diseases such as arthritis and inflammatory bowel disease. In vitro experiments have shown that Aesculioside C inhibits the production of pro-inflammatory cytokines like interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in activated macrophages. These findings suggest that the compound could modulate immune responses and reduce inflammation in chronic conditions.

In addition to its anti-inflammatory effects, Aesculioside C has also exhibited significant antioxidant activity. Oxidative stress is a key contributor to various pathological conditions, including cardiovascular diseases, neurodegenerative disorders, and cancer. Aesculioside C has been shown to scavenge free radicals and protect cellular components from oxidative damage. This property makes it a valuable component in antioxidant formulations and skincare products aimed at combating aging and environmental stressors.

The cardiovascular benefits of Aesculioside C have also been explored in recent research. Studies indicate that this compound may improve endothelial function by enhancing nitric oxide (NO) bioavailability and reducing oxidative stress in vascular endothelial cells. Improved endothelial function is associated with reduced risk of hypertension, atherosclerosis, and other cardiovascular diseases. These findings highlight the potential of Aesculioside C as a natural therapeutic agent for maintaining heart health.

Aesculioside C's neuroprotective effects are another area of active investigation. Preclinical studies have demonstrated that the compound can protect neurons from damage induced by oxidative stress and excitotoxicity. It has also shown promise in models of Alzheimer's disease by reducing amyloid-beta deposition and improving cognitive function in mice. These results suggest that Aesculioside C could be developed into a novel therapeutic for neurodegenerative disorders.

The anticancer potential of Aesculioside C is another intriguing avenue of research. Recent studies have shown that this compound can induce apoptosis in various cancer cell lines while sparing normal cells, indicating its selective cytotoxicity against malignant cells. Mechanistic investigations reveal that Aesculioside C activates caspase pathways and modulates signaling cascades involved in cell proliferation and survival. These findings underscore its potential as a chemotherapeutic agent or adjuvant in cancer treatment regimens.

Despite its numerous biological activities, the mechanism(s) underlying Aesculioside C's actions remain incompletely understood. Ongoing research aims to elucidate the molecular targets and signaling pathways involved in its anti-inflammatory, antioxidant, cardioprotective, neuroprotective, and anticancer effects. Understanding these mechanisms will be essential for optimizing its therapeutic potential and minimizing off-target effects.

The pharmacokinetics and bioavailability of Aesculioside C are critical factors influencing its therapeutic application. Studies on oral administration have revealed moderate absorption rates, with peak plasma concentrations achieved within 2-4 hours post-ingestion. The compound exhibits reasonable stability in physiological conditions but undergoes limited metabolism in the liver before being excreted primarily via urine. These characteristics suggest that Aesculioside C could be suitable for oral formulations targeting chronic diseases requiring sustained release.

In terms of safety profile, preliminary toxicological studies indicate that Aesculioside C is well-tolerated at doses relevant to therapeutic applications. No significant adverse effects were observed in acute or subchronic toxicity models, suggesting a favorable safety margin for human use. However, further long-term studies are needed to confirm its safety profile across different populations.

The commercialization of Aesculioside C as a nutraceutical or pharmaceutical product presents both opportunities and challenges. On one hand, its natural origin, diverse biological activities, and favorable safety profile make it an attractive candidate for health supplements or functional foods targeting inflammation, oxidative stress, cardiovascular health, cognitive function, or cancer prevention/therapy.

On the other hand, challenges such as large-scale extraction from plant sources or cost-effective synthesis need to be addressed to ensure sustainable supply chains for commercial applications. Additionally, regulatory approval processes require robust preclinical data supporting efficacy claims while ensuring compliance with Good Manufacturing Practices (GMPs) during production.

In conclusion,Aesculioside C represents a promising natural product with multifaceted biological activities that hold great potential for therapeutic applications across various disease areas.The ongoing advancements in understanding its molecular mechanisms,bioavailability,and safety profiles will undoubtedly pave the way for its translation into clinical practice.The integration of cutting-edge research methodologies with traditional herbal medicine knowledge will continue to unlock new insights into this fascinating compound's therapeutic potential.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)